BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29092674)

  • 21. Combination of autoantibodies against different histone proteins influences complement-dependent phagocytosis of necrotic cell material by polymorphonuclear leukocytes in systemic lupus erythematosus.
    Gullstrand B; Lefort MH; Tydén H; Jönsen A; Lood C; Johansson A; Jacobsen S; Truedsson L; Bengtsson AA
    J Rheumatol; 2012 Aug; 39(8):1619-27. PubMed ID: 22753651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopathogenesis of lupus and lupus nephritis: recent insights.
    Kewalramani R; Singh AK
    Curr Opin Nephrol Hypertens; 2002 May; 11(3):273-7. PubMed ID: 11981256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.
    Rekvig OP; Van der Vlag J
    Semin Immunopathol; 2014 May; 36(3):301-11. PubMed ID: 24763531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
    Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers.
    Dumestre-Pérard C; Clavarino G; Colliard S; Cesbron JY; Thielens NM
    Autoimmun Rev; 2018 Sep; 17(9):890-899. PubMed ID: 30009962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
    Wisnieski JJ; Jones SM
    J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
    Verma J; Arora V; Marwaha V; Kumar A; Das N
    Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of kidney disease in systemic lupus erythematosus.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2009 Sep; 21(5):489-94. PubMed ID: 19584729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement and systemic lupus erythematosus.
    Walport MJ
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S279-93. PubMed ID: 12110148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S; Vanhecke D; Trendelenburg M
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of lupus nephritis: an update.
    Tang S; Lui SL; Lai KN
    Nephrology (Carlton); 2005 Apr; 10(2):174-9. PubMed ID: 15877678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systemic lupus erythematosus--a contemporary view of its genetic determination, immunopathogenesis and therapy].
    Buc M; Rovenský J
    Epidemiol Mikrobiol Imunol; 2009 Feb; 58(1):3-14. PubMed ID: 19358447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic autoantibodies in lupus nephritis.
    Waldman M; Madaio MP
    Lupus; 2005; 14(1):19-24. PubMed ID: 15732283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating immune complexes and the complements system in lupus nephropathy.
    Serban MG
    Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.
    Morell M; Pérez-Cózar F; Marañón C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extreme gonococcal susceptibility associated with acquired complement deficiency secondary to hypocomplementemic urticarial vasculitis and systemic lupus erythematosus.
    Belfeki N; Zayet S; Hamrouni S; Diamantis S; Boutboul D
    J Infect Chemother; 2022 Feb; 28(2):308-310. PubMed ID: 34736815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
    Hara A; Furuichi K; Yamahana J; Yasuda H; Iwata Y; Sakai N; Shimizu M; Kaneko S; Wada T
    J Rheumatol; 2016 Jul; 43(7):1328-34. PubMed ID: 27134248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
    Zhuang H; Han S; Li Y; Kienhöfer D; Lee P; Shumyak S; Meyerholz R; Rosadzinski K; Rosner D; Chan A; Xu Y; Segal M; Sobel E; Yang LJ; Hoffmann MH; Reeves WH
    Arthritis Rheumatol; 2016 Dec; 68(12):2917-2928. PubMed ID: 27274010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A; Pipi E; Soufleros K
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.